EPCAM and cancer: Investigation of significantly differently regulated parameters (Figure S3B) showed that samples from mCRC patients induced less effective ADCC as measured by a reduced LDH release (Figure 4D) or induction of dead (DAPI+AnnexinV+) EpCAM+ cancer cells (Figure 4E).